435 related articles for article (PubMed ID: 25784643)
1. "Multidrug-resistant tuberculosis" may be nontuberculous mycobacteria.
Shahraki AH; Heidarieh P; Bostanabad SZ; Khosravi AD; Hashemzadeh M; Khandan S; Biranvand M; Schraufnagel DE; Mirsaeidi M
Eur J Intern Med; 2015 May; 26(4):279-84. PubMed ID: 25784643
[TBL] [Abstract][Full Text] [Related]
2. Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients.
Gao J; Pei Y; Yan X; Shi G; Li T; Gao M; Liu Y; Wang Y; Shu W; Li L; Pang Y
Int J Infect Dis; 2020 Nov; 100():196-198. PubMed ID: 32890726
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China.
Lan R; Yang C; Lan L; Ou J; Qiao K; Liu F; Gao Q
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1669-75. PubMed ID: 22118176
[TBL] [Abstract][Full Text] [Related]
4. Implication of Negative GeneXpert Mycobacterium tuberculosis/Rifampicin Results in Suspected Tuberculosis Patients: A Research Study.
Kusumaningrum D; Mertaniasih NM; Soedarsono S; Setiawati R; Pradipta CP
Int J Mycobacteriol; 2024 Apr; 13(2):152-157. PubMed ID: 38916385
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.
Hwang SM; Lim MS; Hong YJ; Kim TS; Park KU; Song J; Lee JH; Kim EC
Tuberculosis (Edinb); 2013 Nov; 93(6):642-6. PubMed ID: 23988279
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India.
Das S; Mishra B; Mohapatra PR; Preetam C; Rath S
Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing nontuberculous mycobacteria from multidrug-resistant Mycobacterium tuberculosis, China.
Xu K; Bi S; Ji Z; Hu H; Hu F; Zheng B; Wang B; Ren J; Yang S; Deng M; Chen P; Ruan B; Sheng J; Li L
Emerg Infect Dis; 2014 Jun; 20(6):1060-2. PubMed ID: 24856951
[No Abstract] [Full Text] [Related]
8. [Study on pulmonary lesions in which nontuberculous mycobacteria were detected by percutaneous aspiration--a proposal to add "culture positivity of percutaneous aspiration material" to the bacteriological diagnostic criteria of pulmonary nontuberculous mycobacterial diseases].
Nakahara Y; Mochizuki Y; Kawamura T; Sasaki S; Morimoto A; Mizumori Y; Tsukamoto H; Watanabe E; Yokoyama T
Kekkaku; 2013 Mar; 88(3):283-9. PubMed ID: 23672168
[TBL] [Abstract][Full Text] [Related]
9. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
Wang MS; Wang JL; Wang XF
BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
[TBL] [Abstract][Full Text] [Related]
10. Nontuberculous mycobacteria among pulmonary tuberculosis patients: a retrospective Belgian multicenter study.
De Keukeleire S; Mathys V; Van den Wijngaert S; Van De Vyvere M; Jonckheere S; De Beenhouwer H; De Bel A; Arrazola de Onate W; Wanlin M; Piérard D; Nulens E; Saegeman V
Acta Clin Belg; 2017 Feb; 72(1):45-48. PubMed ID: 27345031
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
Cadelis G; Ducrot R; Bourdin A; Rastogi N
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
[TBL] [Abstract][Full Text] [Related]
12. Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous Mycobacteria.
Lee MR; Cheng A; Huang YT; Liu CY; Chung KP; Wang HC; Liang SK; Liao CH; Yu CJ; Hsueh PR
J Clin Microbiol; 2012 Oct; 50(10):3398-401. PubMed ID: 22855520
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients.
Huang CT; Tsai YJ; Shu CC; Lei YC; Wang JY; Yu CJ; Lee LN; Yang PC;
Respir Med; 2009 Oct; 103(10):1484-91. PubMed ID: 19467850
[TBL] [Abstract][Full Text] [Related]
14. Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.
Hu C; Huang L; Cai M; Wang W; Shi X; Chen W
BMC Infect Dis; 2019 Sep; 19(1):764. PubMed ID: 31477038
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.
Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M
Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951
[TBL] [Abstract][Full Text] [Related]
17. Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014.
El-Zeenni N; Chanoine S; Recule C; Stahl JP; Maurin M; Camara B
Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):233-240. PubMed ID: 29067624
[TBL] [Abstract][Full Text] [Related]
18. New assay to diagnose and differentiate between Mycobacterium tuberculosis complex and nontuberculous mycobacteria.
Ustinova VV; Smirnova TG; Sochivko DG; Varlamov DA; Larionova EE; Andreevskaya SN; Andrievskaya IY; Kiseleva EA; Chernousova LN; Ergeshov A
Tuberculosis (Edinb); 2019 Jan; 114():17-23. PubMed ID: 30711153
[TBL] [Abstract][Full Text] [Related]
19. Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia.
Bonnet M; San KC; Pho Y; Sok C; Dousset JP; Brant W; Hurtado N; Eam KK; Ardizzoni E; Heng S; Godreuil S; Yew WW; Hewison C
Emerg Infect Dis; 2017 Jul; 23(7):1139-1147. PubMed ID: 28628437
[TBL] [Abstract][Full Text] [Related]
20. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
